Cyclophosphamide (generic), Cytoxan

Cyclophosphamide (generic), Cytoxan Newswire (Page 8)

Comprehensive Real-Time News Feed for Cyclophosphamide (generic), Cytoxan. (Page 8)

Results 141 - 160 of 253 in Cyclophosphamide (generic), Cytoxan

  1. Dominion Fertility Clinicians on How Egg Freezing Offers Hope For Cancer PatientRead the original story

    Apr 30, 2014 | Examiner.com

    According to clinicians at Dominion Fertility, new reproductive technology is bringing hope to cancer patients who want to preserve their chance to bear children after treatment.

    Comment?

  2. Radiological Case: An unusual case of an anterior mediastinal massRead the original story

    May 1, 2014 | Applied Radiology

    A 24-year-old man who presented with hoarseness of voice was found to have left vocal cord palsy on laryngoscopic examination done outside.

    Comment?

  3. Dominion Fertility Clinicians Discuss How Egg Freezing Offers Hope For Cancer PaRead the original story

    Apr 30, 2014 | Examiner.com

    According to clinicians at Dominion Fertility, new reproductive technology is bringing hope to cancer patients who want to preserve their chance to bear children after treatment.

    Comment?

  4. Metro Property Group CEO Sameer BeydounRead the original story

    Apr 30, 2014 | Examiner.com

    According to clinicians at Dominion Fertility, new reproductive technology is bringing hope to cancer patients who want to preserve their chance to bear children after treatment.

    Comment?

  5. Prompt plasma exchanges and immunosuppressive treatment improves the...Read the original story

    Apr 30, 2014 | Kidney International

    E-mail: arvindbagga@hotmail.com Antibodies to complement factor H are an uncommon cause of hemolytic uremic syndrome .

    Comment?

  6. Cycles of transient high-dose cyclophosphamide administration and...Read the original story

    Apr 30, 2014 | Cancer Gene Therapy

    Correspondence: Dr WSM Wold, Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, 1100 South Grand Boulevard, St Louis, MO 63104, USA.

    Comment?

  7. The omics of triple-negative breast cancers.Read the original story

    Apr 24, 2014 | CiteULike

    Triple-negative breast cancers do not represent a single disease subgroup and are often aggressive breast cancers with poor prognoses.

    Comment?

  8. BusulfanRead the original story

    Mar 7, 2012 | ASHP

    Prasco acquired GlaxoSmithKline's Myleran oral tablets in September, 2011. GlaxoSmithKline states supplies were limited due to increased demand.2,3 Busulfan is an alkylating agent.

    Comment?

  9. CNS events in elderly patients with aggressive lymphoma treated with...Read the original story

    Apr 19, 2014 | CiteULike

    CNS events in elderly patients with aggressive lymphoma treated with modern chemotherapy with or without rituximab: an analysis of patients treated in the RICOVER-60 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and ... (more)

    Comment?

  10. Lupus nephritis: maintenance therapy for lupus nephritis--do we now have a plan?Read the original story

    Apr 19, 2014 | CiteULike

    Lupus nephritis increases the morbidity and mortality of patients with SLE. This review compares the randomized, controlled trials that examined various maintenance regimens available to treat LN.

    Comment?

  11. Lupus nephritis: induction therapy in severe lupus nephritis--should...Read the original story

    Apr 19, 2014 | CiteULike

    Severe lupus nephritis is an aggressive disease that requires an aggressive approach to treatment.

    Comment?

  12. DepoVax Technology Selected for HPV related Cancer TrialsRead the original story

    Apr 17, 2014 | Biopharm

    Dana-Farber has been awarded a research grant of $1.2 million for clinical evaluation of its cancer vaccine.

    Comment?

  13. Research Conducted by I.H. Bartelink and Co-Authors Has Provided New Information about MesylatesRead the original story

    Apr 16, 2014 | Hispanic Business

    In line with strategies explored in adults, patient outcomes may be optimized by replacing cyclophosphamide with or without melphalan with fludarabine ."

    Comment?

  14. Study Findings from Institute of Cardiology Broaden Understanding of Stem CellsRead the original story

    Apr 16, 2014 | Hispanic Business

    Cardiotoxicity of such therapy has not yet been fully elucidated." Our news editors obtained a quote from the research from the , "Noninvasive approaches allowing to evaluate an autonomic control of the heart function include analyses of both heart rate variability and heart rate turbulence .

    Comment?

  15. Patent Application Titled 'Derivatives of Sulindac, Use Thereof and...Read the original story

    Apr 16, 2014 | Hispanic Business

    Cancer has been reported as the leading cause of death in with one of every four Americans likely to be diagnosed with the disease.

    Comment?

  16. Immunovaccine Highlights Enhanced Anti-Tumor Activity of Cancer...Read the original story

    Apr 16, 2014 | Hispanic Business

    " or "IMV") , a clinical stage vaccine company, presented positive data from clinical and preclinical vaccine studies, including DPX-Survivac, the company's lead therapeutic cancer vaccine, this weekend at the highlighted results demonstrating that metronomic cyclophosphamide , an immune modulating agent, enhanced the immunogenicity of DepoVax ... (more)

    Comment?

  17. Emerging Therapies in Development for Relapsed/Refractory CLL/SLL are ...Read the original story

    Apr 10, 2014 | Freshnews

    Decision Resources Group finds that the effect of a therapy on overall survival and progression-free survival are attributes that most influence surveyed U.S. and European hematological oncologists' prescribing decisions for relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma .

    Comment?

  18. Puma Biotechnology Presents Positive PB272 Phase II Data from I-SPY 2 TRIALRead the original story

    Apr 9, 2014 | Hispanic Business

    The I-SPY 2 TRIAL is a randomized Phase II clinical trial for women with newly diagnosed Stage 2 or higher breast cancer that addresses whether adding investigational drugs to standard chemotherapy in the neoadjuvant setting is better than standard chemotherapy.

    Comment?

  19. Puma Biotechnology Announces Presentation of Positive PB272 Phase II Data from I-SPY 2 TRIALRead the original story

    Apr 7, 2014 | Freshnews

    Puma Biotechnology, Inc. , a development stage biopharmaceutical company, today announced the presentation of positive results from the Phase II clinical trial of Puma's investigational drug PB272 for the neoadjuvant treatment of breast cancer in an oral presentation at the American Association for Cancer Research Annual Meeting 2014 in San Diego, ... (more)

    Comment?

  20. Immunovaccine's DepoVax(TM) Technology Underpins New Experimental...Read the original story

    Apr 8, 2014 | Hispanic Business

    In a competitive process, Dana-Farber has been awarded a research grant of annual meeting.

    Comment?